Popular Articles

Depuy Mitek Launches Small Joint Anchors Now Pre-Loaded With Orthocord(R) - Small, Strong And Secure Solutions For Soft Tissue Fixation
DePuy Mitek, Inc., a leading orthopaedics sports medicine company, announced that all of its QUICKANCHOR® Plus suture anchors for small joint repair are now available pre-loaded with ORTHOCORD®. ORTHOCORD is the only high-strength, partially absorbable orthopedic suture on the market designed to provide a supple solution for soft tissue fixation while maintaining strength and knot security. The QUICKANCHOR Plus small joint suture anchors with ORTHOCORD include the MINI, MINILOK™, MICRO and MICROFIX™ product families.
generic viagra online
Medical Care Sought In Mexico By Nearly 1 Million Californians Annually
Driven by rising health care costs at home, nearly 1 million Californians cross the border each year to seek medical care in Mexico, according a new paper by UCLA researchers and colleagues published in the journal Medical Care.
News of the day
States To Pursue New Integrated Care Approaches For Dual Eligibles
As the nation debates health reform options, the Center for Health Care Strategies (CHCS) is launching Transforming Care for Dual Eligibles , a state initiative to test innovative care models for people who are dually eligible for Medicare and Medicaid ("dual eligibles"). Colorado, Maryland, Massachusetts, Michigan, Pennsylvania, Texas, and Vermont will implement strategies to improve care and control costs for dual eligibles, a high-need population with health care costs nearly five times those of other Medicare beneficiaries. The program is made possible through support from The Commonwealth Fund.
Nutrition

FDA Alerts Patients To Medtronic Pacemaker Recall

The U.S. Food and Drug Administration is alerting patients to the Class I recall of certain Medtronic Kappa and Sigma pacemakers. These devices may fail due to a separation of wires that connect the electronic circuit to other pacemaker components, such as the battery. Patients with malfunctioning pacemakers may experience a return of symptoms associated with abnormal heart rate, such as fainting or lightheadedness. In rare cases, pacemaker-dependent patients may experience serious injury or even death. There are more than 1.7 million Kappa or Sigma pacemakers implanted in patients throughout the world. Of those, only about 21,000 pacemakers are affected by this recall, most of which have been implanted in patients for five years or longer. Medtronic Inc. issued a letter to physicians alerting them to this problem on May 18. The company communicated with patients via letter on May 27. The affected pacemakers are Kappa Series 600/700/900 and Sigma Series 100/200/300. Patients with these models of Kappa and Sigma pacemakers should determine if their pacemaker is part of this recall by contacting Medtronic at 800-505-4636 or going to their Web site at http://www.KappaSigmaSNList.medtronic.com. Patients who have these recalled pacemakers and those who are unsure if their pacemakers are affected should follow up with their primary care physician or cardiologist. Through standard medical device reporting requirements, the FDA became aware of possible problems and worked with the company to address them. The FDA classified this voluntary recall as Class I, indicating reasonable probability that the use of the device will cause serious adverse health consequences or death. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):